Past events

This course examines the uses and limits of new methods for assessing health technologies in the early stages of research and development. Through real-world case studies and interactive learning, participants will learn how to frame the assessment, generate evidence, and produce insights relevant for decision-making, reflecting that information and implementation may be uncertain.

Europe's premier conference in the cell and gene therapy industry today.

Following a successful AXS26 Summit, Asembia is excited to be planning next year’s conference comprising networking sessions, exhibits and more. Each year, Asembia’s Specialty Pharmacy Summit is at the epicenter of the pharmacy industry, providing a unique opportunity for stakeholders throughout the industry to understand challenges, generate solutions and define the future.

The ABPI exists to make the UK the best place in the world to research, develop and access medicines and vaccines to improve patient care. We represent companies of all sizes which invest in making and discovering medicines and vaccines to enhance and save the lives of millions of people around the world.

The global collaborative network for leading pharma innovators

This course examines the uses and limits of new methods for assessing health technologies in the early stages of research and development. Through real-world case studies and interactive learning, participants will learn how to frame the assessment, generate evidence, and produce insights relevant for decision-making, reflecting that information and implementation may be uncertain.

This course offers a practical overview of market access and its application in business development and clinical strategy decisions. You’ll gain essential knowledge of payer expectations and HTA systems in Europe, and learn how access-related data should inform strategic decision-making. Through real-world examples and interactive group work, you’ll be equipped to make access-aware decisions in business development and clinical strategy

This course offers a clear and structured framework for value pricing to get market access in pharma. It provides an overview of the key concepts, frameworks, and evidence-based approaches to get prices right and access delivered. Whether you are involved directly in pricing or work in a related function, this course will help you build the essential knowledge needed to contribute more effectively to pricing and market access decisions.

BioTrinity is OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The delegate mix comprises early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and broad range of valued service providers.

Covering Clinical Development, Bioprocessing & Manufacturing, Cancer Immunotherapy and much more. The Start-to-Finish of Vaccines from research, immune profiling & clinical trials to manufacture and access.

Budget impact analysis (BIA) plays an important role in healthcare decision making, helping stakeholders understand the financial and health implications of new interventions. A clear, structured approach is essential. In just 1 hour, gain an understanding of the key steps to approaching budget impact analysis and come away with practical concepts that can be immediately applied.

Join us at this exceptional event, where senior managers, policymakers, commissioners, patients, frontline staff, and industry leaders unite in an inspiring and collaborative atmosphere

The Advanced Therapies Congress brings together speakers from across the entire value chain of cell and gene therapy development, forward-thinking pharma, biotech and start-up companies, researchers, clinicians, academics, HTAs, payers and regulators.

his two-day event is designed as a dedicated platform for stakeholders across the UK and European healthcare ecosystem to explore the evolving role of Real-World Evidence (RWE) in shaping market access, pricing, and reimbursement strategies. With increasing pressure to deliver cost-effective, evidence-based care, this summit brings together thought leaders from across pharma, biotech, regulators, payers, HTA bodies, and digital health to address the region’s most pressing access and pricing challenges.

This course offers a clear and practical introduction to statistical thinking tailored to the needs of Medical Affairs. You will learn the essential principles behind statistical analysis, develop the ability to critically assess the validity and relevance of study findings, and gain techniques to clearly communicate statistical results in a medical context.

The goal of this course is to demystify market access for anyone involved. You will be equipped with clear schematic overviews of the market access systems in Europe’s major markets as a resource for reference in your daily work.

The Festival of Biologics brings together pharma & biotech, academics, research institutes, regulators, patients groups and payers together with their partners across the value chain to bring you from discovery to market.

The AMR Conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and specific challenges faced by the innovation ecosystem in bringing new antimicrobial treatments and diagnostics to the market. The conference is the one-stop shop to catch up with the latest trends in the development of AMR products, by covering scientific, regulatory, financial and policy topics.

World Evidence, Pricing and Access Congress is Europe’s largest congress in market access, pricing and evidence featuring 300 speakers, 8 tracks and 1500+ attendees from pharma, biotech and Payers/HTAs.